Data Loading...
The global frontotemporal disorder treatment market is projected to grow at a considerable CAGR of around 5 Flipbook PDF
The global frontotemporal disorder treatment market is projected to grow at a considerable CAGR of around 5
118 Views
11 Downloads
FLIP PDF 348.7KB
Orion Market Research
Global Frontotemporal Disorder Treatment Market Size, Competitive Analysis, Share, Forecast- 2020-2026 Request a Free Sample @ https://www.omrglobal.com/request-sample/frontotemporaldisorder-treatment-market
Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: [email protected] Contact no: +91 780-304-0404
The global frontotemporal disorder treatment market is projected to grow at a considerable CAGR of around 5% during the forecast period (2020-2026). The increasing prevalence of frontotemporal disorder along with the growing geriatric population which is more susceptible to this kind of disorder is expected to be key factors promoting the growth of the global frontotemporal disorder treatment market. According to the World Health Organization (WHO), in 2019 around 50 million people are living with dementia and the number is anticipated to get three times by 2050. Moreover, nearly 10 million new cases are anticipated to increase every year. Frontotemporal disorders are forms of dementia caused by a family of brain disorders known as frontotemporal lobar degeneration (FTLD). Get Free Sample Copy @ https://www.omrglobal.com/request-sample/frontotemporaldisorder-treatment-market With the growing number of patients suffering from the frontotemporal disorder, several private or non-profit organizations are actively focusing on drug development procedures. For instance, in 2019, the National Institute of Health (NIH) had spent nearly $387 million on research projects for Alzheimer's Disease-Related Dementias (ADRD). Therefore, the rising funding initiatives by a non-profit organization such as the Bluefield Project Organization, CurePSP, Inc. Alzheimer Discovery Foundation (ADDF), Tau Consortium Organization, Association for Frontotemporal Degeneration (AFTD) to support drug research initiatives is anticipated to drive the growth of the frontotemporal disorder treatment industry across the globe. However, stringent government regulations, lack of awareness, and lack of novel therapies are the key factors anticipated to hinder the growth of the global market. Browse
for
Full
Report
Description@
https://www.omrglobal.com/industry-
reports/frontotemporal-disorder-treatment-market Market Segmentation Global Frontotemporal Disorders Treatment Market by Drug Class
Cognitive Enhancers
Antipsychotics
Antidepressants
CNS Stimulant
Other
Global Frontotemporal Disorders Treatment Market by Disease Indication
Frontotemporal Dementia
Primary Progressive Aphasia
Movement Disorder
Global Frontotemporal Disorders Treatment Market by Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Others
Regional Analysis North America
US
Canada
Europe
UK
Germany
Italy
Spain
France
Rest of Europe
Asia-Pacific
China
India
Japan
Rest of Asia-Pacific
Rest of the World Company Profiles
Allergan PLC
Apotex Inc.
AstraZeneca PLC
Bausch Health Companies, Inc.
Eli Lily and Co.
F. Hoffmann-La Roche Ltd.
GlaxoSmithKline PlPLC
Intas Pharmaceutical Ltd.
Johnson & Johnson Service, Inc.
Merck & Company, Inc.
Mylan N.V.
Novartis AG
Pfizer, Inc.
Sanofi S.A.
Teva Pharmaceuticals Industries, Ltd.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/frontotemporal-disorder-treatmentmarket About Orion Market Research Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact: Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: [email protected] Contact no: +91 780-304-0404